Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
Lixisenatide: evidence for its potential use in the treatment of type 2 diabetes
Clinical Evidence: Anxiety Risk on GLP-1 Receptor Agonists Major semaglutide trials, including STEP and SUSTAIN programs, reported anxiety in fewer than 3% of treatment participantsrates comparable to placebo control groups
The availability of both injectable and oral formulations allows for tailored treatment approaches based on individual needs
Efficacy and tolerability of pharmacological interventions on metabolic disturbance induced by atypical antipsychotics in adults: a systematic review and network meta-analysis
US$ 24.48
US$ 29.77
US$ 20.01
US$ 29.01
US$ 28.67
US$ 27.63
